Pancreatic Cancer Research

ResearcherHenan University of Chinese MedicineActive in the last 2 years

Zhenqiang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1736-1289; OpenAlex author ID A5018229662. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. RGD peptide/dextran sulfate-based nanocarriers loaded with triptolide for double-targeted apoptosis of both tumor cells and M2-like TAMs in pancreatic cancer t… Last author DOI 10.1016/j.ijbiomac.2025.144032↗
  2. Lycium barbarum Polysaccharide-Stabilized Selenium Nanoparticles Deliver Triptolide to Induce Apoptosis for Pancreatic Cancer In Vitro and In Vivo. Co-author DOI 10.1021/acsomega.4c04743↗
  3. Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer. Co-author DOI 10.1080/10717544.2021.2018521↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huahui Zeng · 2 shared papers, 2022–2025 · strength 0.41
  2. Xiangxiang Wu · 2 shared papers, 2022–2025 · strength 0.40
  3. Xiaofang Li · 1 shared paper, 2025 · strength 0.27
  4. Yaning Ge · 1 shared paper, 2025 · strength 0.26
  5. Zhengxian Zhang · 1 shared paper, 2025 · strength 0.26
  6. Huahui Zeng · 1 shared paper, 2025 · strength 0.26
  7. Xiaohu Zeng · 1 shared paper, 2022 · strength 0.15
  8. Xiaoke Tan · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.